Therefore, among glycolysis-related genes, PGK1 may play the most critical role in the glycolysis process of ovarian cancer, and targeted drugs for PGK1 may effectively improve the survival of patients with ovarian cancer. Here, PGK1 is linked to ovarian carcinoma.